A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
El tratamiento está encaminado a mejorar la función del hígado y garantizar que haya suficiente volumen de sangre en el cuerpo y que el corazón esté bombeándola de manera adecuada.
Esta enfermedad generalmente se trata de la misma manera como se trata una insuficiencia renal por cualquier otra causa.
El resultado predecible es desalentador y la muerte generalmente ocurre como resultado de infecciones secundarias o hemorragia.
Esta enfermedad se diagnostica generalmente en el hospital, durante el tratamiento de un trastorno hepático.
Garcia-Tsao G. Cirrhosis and its sequellae. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier. 2007: chap 157.
Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.800.492.5538